z-logo
open-access-imgOpen Access
Modeling human somite development and fibrodysplasia ossificans progressiva with induced pluripotent stem cells
Author(s) -
Taiki Nakajima,
Mitsuaki Shibata,
Megumi Nishio,
Sanae Nagata,
Cantas Alev,
Hidetoshi Sakurai,
Junya Toguchida,
Makoto Ikeya
Publication year - 2018
Publication title -
development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.754
H-Index - 325
eISSN - 1477-9129
pISSN - 0950-1991
DOI - 10.1242/dev.165431
Subject(s) - fibrodysplasia ossificans progressiva , biology , induced pluripotent stem cell , endochondral ossification , multipotent stem cell , microbiology and biotechnology , stem cell , mesenchymal stem cell , embryonic stem cell , chondrogenesis , population , myotome , somite , heterotopic ossification , anatomy , genetics , progenitor cell , embryogenesis , cartilage , embryo , medicine , environmental health , gene
Somites (SMs) comprise a transient stem cell population that gives rise to multiple cell types, including dermatome (D), myotome (MYO), sclerotome (SCL) and syndetome (SYN) cells. Although several groups have reported induction protocols for MYO and SCL from pluripotent stem cells, no studies have demonstrated the induction of SYN and D from SMs. Here, we report systematic induction of these cells from human induced pluripotent stem cells (iPSCs) under chemically defined conditions. We also successfully induced cells with differentiation capacities similar to those of multipotent mesenchymal stromal cells (MSC-like cells) from SMs. To evaluate the usefulness of these protocols, we conducted disease modeling of fibrodysplasia ossificans progressiva (FOP), an inherited disease that is characterized by heterotopic endochondral ossification in soft tissues after birth. Importantly, FOP-iPSC-derived MSC-like cells showed enhanced chondrogenesis, whereas FOP-iPSC-derived SCL did not, possibly recapitulating normal embryonic skeletogenesis in FOP and cell-type specificity of FOP phenotypes. These results demonstrate the usefulness of multipotent SMs for disease modeling and future cell-based therapies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom